《Table 4 Inhibition activity ofβ-carboline compounds against five bacterial strains*》

《Table 4 Inhibition activity ofβ-carboline compounds against five bacterial strains*》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《β-咔啉衍生物的抗肿瘤及抗菌活性》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录
*The compounds which have no activities were not listed.The values of MIC which are larger than 25μmol/L have not been tested.

支持信息见http://www.cjcu.jlu.edu.cn/CN/10.7503/cjcu20170636.

图表编号XD0019891900    严禁用于非法目的
绘制时间2018.04.10
作者刘莉、马洋洋、王宽、贾云静、李婉、朱华结
绘制单位河北大学医学院、河北大学药学院、河北大学医学院、河北大学药学院、河北大学药学院、河北大学药学院
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 1Inhibition efficiency of crude extracts against毩-glucosidase, maltaseglucoamylase and毬-glucosidase (mean±SD) .》2018.03.01
  2. 《Table 2Inhibition potency of crude extracts against aldose reducase and aldehyde reductase (mean±SD) (μg/m L) .》2018.03.01
  3. 《Table 1 In-vitro inhibition zone diameters of single traditional Chinese herbs against S.aureus isolate and standard str》2018.06.01
  4. 《Table 1 In-vitro inhibition zone diameters of single traditional Chinese herbs against S.aureus isolate and standard str》2018.06.01
  5. 《Table 3 Inhibition activity against five human cancer cell lines by MTS assay》2020.03.10
  6. 《Table 3 Inhibition activity against five human cancer cell lines by MTS assay》2020.03.10
  7. 《Table 3 Cytotoxic activities of compounds 1, 2, 3, 4 and 5 (n=3)》2019.02.20
  8. 《Table 4 Structures and activity of prepared compounds based on lead compound 42》2019.05.12
  9. 《表1 化合物1a～1j体外对9种植物病原菌抑菌活性测试抑制率Tab.1 Inhibition effect of compounds 1a～1j against nine kinds of phytopathogenic fungi in》2019.03.18
  10. 《Table 6 Antiviral activities of the test compounds against TMV in vivo at 500 mg/L》2019.05.10
  11. 《Table 5 EC50values of some compounds against X.oryzae》2019.05.10
  12. 《Table 4 Sources of flavonoid compounds and their antifungal activities》2019.01.20
  13. 《Table 2.IC50 values of compounds 1, 2, 4, 6–7, 10, 12–15 and 19 against the corresponding tumor cell lines.》2019.04.01
  14. 《Table 1.The inhibitory activities of compounds 1–19 against cancer cell lines.》2019.04.01
  15. 《Table 2 The inhibition zone diameter (mm) of compounds 1 and 2》2019.02.01
  16. 《Table 2 Antibacterial activity ofα/βCPMBs against multiple strains of MRSA》2019.04.01
  17. 《Table 6 Inhibitory activities of compounds 1—6 and TZOA-1—TZOA-18 against Cdc25B and PTP1B》2019.02.10
  18. 《Table 6 Inhibitory activities of compounds 1—6 and TZOA-1—TZOA-18 against Cdc25B and PTP1B》2019.02.10
  19. 《Table 3 Inhibition activity ofβ-carboline compounds against five human cancer cell lines by MTT assay*》2018.04.10
  20. 《表4 苯甲酸对6种病原菌的毒力测定Table 4 Inhibition virulence of benzoic acid against six plant pathogens》2018.07.01

随机翻阅

《表4 回归模型2的实证结果(被解释变量:国际资本流动)》 《表3 3组并发症发生情况比较（n)》 《表1 2组患者配合程度比较》 《表2 安远灌区现状灌溉制度》 《表2 曲线工况最高运行速度的对比》 《表1 2014～2017年本院骨关节化脓性感染患儿分布情况 (n)》 《表1 医疗设备应用技术专业的就业情况统计表》 《表2 12Cr1MoV力学性能》 《表2 OSCC患者预后影响因素的Cox风险比例回归模型分析》 《表2 2015年内蒙古自治区肝癌发病情况》